Huameng Li
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions 8
- Toxicology top 5%
- Molecular Medicine top 10%
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects 4
- Medicinal Plant Pharmacodynamics Research 3
-
- Computational Drug Discovery Methods 3
-
- Plant-Microbe Interactions and Immunity 3
- Plant Disease Resistance and Genetics 3
-
- Genomics and Phylogenetic Studies 3
- Fungal and yeast genetics research 3
- Cited by
- OncologyToxicologyMolecular Medicine
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Huameng Li
18 papers receiving 930 citations
Peers
Comparison fields: 5 of 93
- Oncology 335
- Toxicology 41
- Molecular Medicine 57
- Immunology 143
- Pharmacology 59
Countries citing papers authored by Huameng Li
This map shows the geographic impact of Huameng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huameng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huameng Li more than expected).
Fields of papers citing papers by Huameng Li
This network shows the impact of papers produced by Huameng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huameng Li. The network helps show where Huameng Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huameng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 50 | |
| 2 | 2017 | 36 | |
| 3 | 2017 | 14 | |
| 4 | 2015 | 83 | |
| 5 | 2015 | 198 | |
| 6 | 2015 | 28 | |
| 7 | 2014 | 128 | |
| 8 | Multiple Ligand Simultaneous Docking (MLSD) and Its Applications to Fragment Based Drug Design and Drug Repositioning | 2012 | 4 |
| 9 | 2012 | 0 | |
| 10 | 2011 | 54 | |
| 11 | 2011 | 26 | |
| 12 | 2011 | 66 | |
| 13 | 2010 | 41 | |
| 14 | 2007 | 48 | |
| 15 | 2007 | 7 | |
| 16 | 2007 | 23 | |
| 17 | 2006 | 48 | |
| 18 | 2005 | 78 | |
| 19 | 1997 | 14 |
About Huameng Li
Huameng Li is a scholar working on Molecular Medicine, Pharmacology and Oncology, having authored 19 papers that have together received 946 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (8 papers), Inflammatory mediators and NSAID effects (4 papers), Computational Drug Discovery Methods (3 papers), Plant-Microbe Interactions and Immunity (3 papers), Plant Disease Resistance and Genetics (3 papers), Genomics and Phylogenetic Studies (3 papers), Medicinal Plant Pharmacodynamics Research (3 papers) and Fungal and yeast genetics research (3 papers). The work is most often cited by research in Oncology (335 citations), Toxicology (41 citations) and Molecular Medicine (57 citations). Huameng Li has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Jiayuh Lin, Chenglong Li, Guang Liang, Shulin Yang, Chengguang Zhao, Huey‐Jen Lin, David Jou, Hui Xiao, Chenglong Li and Aiguo Liu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.